Clinical trial registry record

Improving Patient Safety by Supporting Older Adults in Managing Sleep Problems.

A registered study indexed because it matched monitored longevity research terms. Registry status: Active Not Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Active Not Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated August 3, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06584513
Last registry update
August 3, 2026
Status
Active Not Recruiting
Phase
Phase not reported
Sponsor
Insel Gruppe AG, University Hospital Bern
Enrollment
470
Countries
Belgium, Greece, Norway, Poland, Spain, Switzerland
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Active Not Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · TREATMENT · DOUBLE
Evidence population
Human clinical study registration
Participants
470
Population
ALL · 65 Years
Duration
2024-11-18 to 2027-07-31
Intervention
Specific tapering plan for sleep medication, educational and cognitive behavioural therapy elements
Comparator
Control/Usual care
Outcomes measured
BSH discontinuation — 12 months after enrollment; Quality of sleep — 12 months after enrollment; Use of a substitute medication for sleep — 2 months, 6 months, and 12 months after enrollment; BSH discontinuation discussion with HCP — 1 month, 2 months, and 6 months after enrollment; Benzodiazepines (BSH) discontinuation or dose reduction — 2 months and 6 months after enrollment; BSH adverse events — 12 months after enrollment; Quality of sleep — 2 months and 6 months after enrollment; BSH standardized daily dose intake — 2 months, 6 months, and 12 months after enrollment; Health-related quality of life — 2 months, 6 months, and 12 months after enrollment; Withdrawal symptoms from BSH discontinuation — 2 months and 6 months after enrollment
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Sleep · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.

sleep
Read the original source →Export JSON